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A B S T R A C T
Hypertension is an important risk factor for age-related cognitive decline and neuronal pathologies. Studies have shown a corre-
lation between hypertension, disruption in neurovascular coupling and cerebral autoregulation, and cognitive decline. However,
the mechanisms behind this are unclear. To further understand this, it is advantageous to study neurovascular coupling as hy-
pertension progresses in a rodent model. Here, we use a longitudinal functional MRI (fMRI) protocol to assess the impact of
hypertension on neurovascular coupling in spontaneously hypertensive rats (SHRs). Eight female SHRs were studied at 2, 4,
and 6 months of age, as hypertension progressed. Under an IV infusion of propofol, animals underwent fMRI, functional MR
spectroscopy, and cerebral blood flow (CBF) quantification to study changes in neurovascular coupling over time. Blood pressure
significantly increased at 4 and 6 months (P < .0001). CBF significantly increased at 4 months old (P < .05), in the acute stage
of hypertension. The size of the active region decreased significantly at 6 months old (P < .05). Change in glutamate signal
during activation, and N-acetyl-aspartate (NAA) signal, remained constant. This study shows that, while cerebral autoregulation
is impaired in acute hypertension, the blood oxygenation-level-dependent (BOLD) response remains unaltered until later stages.
At this stage, the consistent NAA and glutamate signals show that neuronal death has not occurred, and that neuronal activity is
not affected at this stage. This suggests that neuronal activity and viability is not lost until much later, and changes observed
here in BOLD activity are due to vascular effects.
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Introduction
In recent decades, evidence has shown a role for the vas-
cular system in age-related cognitive decline and age-related
neurodegeneration.1 Hypertension is now widely accepted
as a risk factor for cognitive decline and neurodegenerative
disease.2 Functional MRI (fMRI) studies in humans have
shown impaired cerebral blood flow (CBF) and diminished
blood oxygenation-level-dependent (BOLD) response in a
number of brain regions in hypertensive subjects, as well as
disruption to functional connectivity.3 The mechanisms behind
these changes in neurovascular coupling are currently unclear,
although are thought to begin as adaptive responses to acute
hypertension, which are protective in the short term. However,
in chronic hypertension, these changes are thought to cause im-
pairments in functional hyperemia in the long term, leading to
hypoxia in neurons, contributing to factors, such as oxidative
damage.4 As rodent models of hypertension exist,5 it is possi-
ble to apply longitudinal fMRI methods to reveal how vascular
changes correlate with changes in neuronal activity as hyper-
tension progresses.
Arterioles and capillaries exhibit adaptation to acute hyper-
tension shortly after onset, and these adaptations are thought to
maintain cerebral autoregulation and be neuroprotective in the
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short term. The initial phase of remodeling, eutrophic remod-
eling, is thought to improve the vessel wall’s resistance to stress
and reduce CBF to healthy levels for short periods of time.6
This phase does not include an increase in the mass of smooth
muscle or pericytes, and is reversible if hypertension is resolved.
In chronic hypertension, permanent changes occur due to hy-
pertrophic remodeling, in which smooth muscle and pericytes
grow thicker due to collagen deposition. While this prevents
damage from increased stress and reduces CBF, this increased
thickness reduces vascular reactivity and functional hyperemia,
as well as blood-brain barrier permeability.7
Such changes are reflected in human imaging studies where
hypertension has been shown to affect task-related BOLD re-
sponse, and genetic risk of hypertension has been shown to
have an impact on the cognitive and neurovascular function
even before symptomatic onset.8-10 For example, normotensive
patients with family history of hypertension showed a signifi-
cant decrease in BOLD signal intensity in three cognitive re-
gions during a visuospatial task, compared to controls with no
history of hypertension.10 However, another study showed in-
creased BOLD signal in middle-aged hypertensive patients in
multiple regions during a cognitive task, and recruited addi-
tional cortical regions not observed in controls.11
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Other MRI outcome measures also been shown to be af-
fected by hypertension include increases and decreases in
functional connectivity between certain areas correlated with
impaired performance in verbal cognitive tasks.12 This suggests
a combination of pathological changes, where connectivity is
impaired, and compensatory changes where connectivity is in-
creased, within the same cohort as hypertension progresses.
This is also supported by CBF imaging, showing impaired CBF
in the right cortex, with compensatory increases in CBF in the
left cortex.3 Cerebral glucose uptake is also impaired in the hip-
pocampus and in cortical regions connecting to the hippocam-
pus involved in spatial learning.13 Thus, a longitudinal preclini-
cal study of progressive hypertension can improve understand-
ing of the multiple compensatory and pathological changes that
occur.
In this study, we used an MRI protocol investigating the
BOLD signal, resting CBF, changes in metabolite and neuro-
transmitter levels, and functional connectivity to study the ef-
fects of progressive hypertension in spontaneously hypertensive
rats (SHRs) from 2 months old (normotensive) to 6 months old
(chronic hypertension). SHRs are a strain bred from the Wis-
tar Kyoto rat to select for high blood pressure (BP), which are
normotensive for the first 6-8 weeks of life, and then develop
hypertension between 2 and 5 months old.14 Changes to neu-
ronal and vascular activity as hypertension progresses were in-
vestigated using a minimally invasive anesthetic protocol and a
longitudinal study design.15
Methods
Animals
This study was conducted in accordance with the UK Animals
(Scientific Procedures) Act, 1986 and following ethical approval
by the University of Leicester Animal and Welfare Ethical Re-
view Body. All experiments are reported in accordance with
the Animal Research Reporting of In Vivo Experiments (AR-
RIVE) guidelines.16 A total of eight female SHRs (NHsd, En-
vigo, Shardlow, Derbyshire, UK) aged 3 weeks on arrival were
housed in double decker cages (floor area 1,862 cm2, height
38 cm, Techniplast, UK) in two groups of four animals. Ani-
mals were given daily access to a playpen for 2-6 hours. Assum-
ing an effect size of 35%, based on CBF fMRI in normoten-
sive and hypertensive humans,3 power calculations suggested
eight animals to be sufficient to observe this effect across three
time points. Animals were fed PMI 5LF2 diet (Lab Supply, Fort
Worth, TX) ad libitum and mains water that had been ultravio-
let (UV) treated in house (Severn Trent, UK).
Experimental Schedule
After a week of acclimatization to the animal unit, animals were
acclimatized to the playpen in groups of 4 over 2 days, before
putting the entire cohort into one playpen from day 3 onward.
For 1 week, animals were acclimatized to the BP monitoring
equipment, and BP was then taken weekly for the duration of
the study. Animals were weighed prior to all MRI scans. The
first MRI scan was performed between 6 weeks and 2 months
of age, prior to the onset of hypertension, and subsequent scans
were performed at 4 and 6 months of age. Immediately fol-
lowing the final scan, animals were humanely killed using in-
traperitoneal pentobarbitone and trasnscardially perfused with
formaldehyde.
BP Monitoring
BP was taken using a Kent Scientific Coda 4.1 BP monitoring
system (Kent Scientific Corporation, Torrington, CT). Animals
were trained to enter a plastic tube, after which they were sealed
in with a nose cone at one end and cover with a tail hole at the
other. The nose cone was adjusted to prevent the rat turning
around but not to cause discomfort. Two cuffs were placed over
the tail, the occlusion cuff at the base and the detection cuff at
the tip. Fifteen averages were taken, with the first five discarded
as acclimatization to the system, and any averages with motion
artifacts discarded.
Anesthesia Protocol
This study uses an anesthesia propofol initially described by
Griffin et al,17 which we have implemented and refined.15 An-
imals were anesthetized with isoflurane (5% induction; 2-3%
maintenance) in 100% oxygen. Tail vein cannulation was per-
formed before transferring the animals to theMRI cradle. A bo-
lus of 9 mg/kg/min propofol was administered for 1 minute us-
ing a syringe driver (Harvard Apparatus, Cambridge, MA) and
the isoflurane was gradually reduced to 0%, with animals still
breathing 100% oxygen. Respiration was monitored using a res-
piration pillow (Small Animal Instruments Inc., Stony Brook,
NY), temperature monitored using a rectal probe and main-
tained using a fan heater activated when measured tempera-
ture dropped below 37 °C (Small Animal Instruments Inc.),
and heart rate and blood oxygen saturation monitored using
a pulse oximeter (Starr Life Sciences, Oakmont, PA). Copper
electrodes were inserted subcutaneously into the dorsal surface
of the right forepaw between digits 1-2 and 2-3.18 Three minutes
after the bolus ended, a continuous infusion of propofol was
given at 54 mg/kg/h until fMRI and fMRS were completed,
and animals were switched to breathing room air. For the dura-
tion of the time-of-flight (TOF) angiography, T2 weighted struc-
tural scan, and arterial spin labeling (ASL) scan, animals were
given 1.5% isoflurane in 100% oxygen. Following the scan, an-
imals were allowed to recover in a separate cage. Analgesic
cream (EMLA cream, AstraZeneca, UK) was applied to the
forepawwhere electrodes had been removed, and animals were
provided with water and wet food pellets to prevent dehydra-
tion after anesthesia. Animals were awake within 15 minutes
following the removal of anesthesia, and moving freely within
30 minutes, at which point they were returned to their home
cages.
MRI Protocol
This study used an MRI protocol adapted from the multipara-
metric MRI protocol, which we have previously implemented
in healthy, aging rats.15 MRI scans were performed on a 9.4T
Small Animal MRI scanner (Agilent Technologies), using a
72 mmRF volume transmit coil and a 2-channel surface receive
coil (Rapid Biomedical, Rimpar, Germany). Coronal scout im-
ages were used to locate bregma, and three 1.5 mm slices were
selected with bregma in the middle slice. A shimming voxel
with dimensions 10 × 9 × 4.5 mm was positioned to cover the
center of all three slices, excluding nonbrain tissue or tissue out-
side the slices of interest. Fast, automatic shimming technique
by mapping along projections (FASTMAP)19 was used to shim
these slices to a 50% water linewidth between 20 and 35 Hz.
Rats were switched frombreathing oxygen to room air, pumped
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at 2 L/min using an air pump (Wiz-Air, Clarke Tools, Dunstable,
UK). fMRI was performed for 9 minutes using a gradient echo
EPI sequence (TR = 250 milliseconds, TE = 22 milliseconds,
kzero = 8, shots = 2, data matrix = 128 × 128). The forepaw
was stimulated at 10 mV, 10 Hz, and pulse width 1 µs, which
has previously been confirmed to activate somatosensory fibers
without activating nociceptive fibers.17 The stimulus paradigm
used a block design of 60 seconds off and 30 seconds on. Fol-
lowing this, a 4 × 4 × 4 mm voxel was positioned over the
left primary somatosensory cortex, forepaw region (S1FL) at
bregma, and manual shimming was performed to a 50% wa-
ter linewidth of <25 Hz. A localization by adiabatic selective
refocusing (LASER)20 MRS sequence (TR = 2,000 millisec-
onds, TE = 14.54 milliseconds, and 270 arrayed averages) was
used to perform fMRS over 18 minutes, using the same forepaw
stimulation paradigm used for fMRI. For analysis, the first 30
seconds of each “off” block were discarded to allow time for
metabolites to return to baseline levels. Oxygen saturation was
maintained above 80% during functional experiments.21 Ani-
mals were switched back to 100% oxygen and 1.5% isoflurane
after all functional scans were complete, to prevent the risk of
the animal waking up as lidocaine wore off and the tail vein con-
stricted. After being returned to 100% oxygen, a TOF angiog-
raphy scan was performed in order to locate a labeling plane
for ASL, followed by a T2 weighted structural scan. Using the
TOF angiography image, the carotid artery was located and a
labeling plane placed with a gap of –17 mm from bregma. Six
minutes of continuous arterial spin labeling was performed on
a single 1.5 mm slice placed over bregma (TI = 1,500 millisec-
onds, TR = 2,500 milliseconds, TE = 10 milliseconds, shots =
1, kzero = 16, and data matrix = 128 × 128).
Data Analysis
An fMRI analysis pipeline was performed using the FMRIB
software library (FSL www.fmrib.ox.ac.uk/fsl).22 Motion cor-
rection with FMRIB’s linear registration tool (MCFLIRT),23
the rat brain extraction tool (rBET, a modified version of BET
to account for the different shape of the rat brain compared
to humans),24,25 and FMRIB’s automated segmentation tool
(FAST)26 was used for motion correction, brain extraction,
and bias field correction, respectively. Independent component
analysis for artifact removal, using multivariate exploratory lin-
ear optimized decomposition into independent components
(MELODIC),27 was performed prior to time-series analysis in
FMRIB’s expert analysis tool (FEAT)28 to visualize the BOLD
response. Cluster analysis was performed on the first-level
FEAT outputs to determine the number of active voxels, max-
imum % signal change within the cluster, and mean % signal
change across the cluster. In each scan, time to peak was calcu-
lated for each of the six stimulus blocks and averaged, with a
temporal resolution of .5 seconds.29
fMRS spectra were separated into “off” and “on” blocks and
averaged using the MATLAB FID-A toolkit.30 The two spec-
tra were analyzed using the TARQUIN MRS analysis pack-
age (www.tarquin.sourceforge.net) to determine relative con-
centrations of glutamate. Metabolite concentrations from “off”
blocks were subtracted from “on” blocks to determine the dif-
ference in glutamate concentration, and the difference in gluta-
mate change (Glu) was averaged across subjects. “Off” blocks
were also used to quantify N-acetyl-aspartate (NAA) and inos-
itol, used as markers of neuronal viability and inflammation,
respectively.
Control and tag ASL images were first concatenated into a
single image of two volumes. The Oxford ASL toolkit for FSL
was used to subtract the tag image from the control image to
create a difference image. FSLmaths was used to apply a mod-
ified Bloch equation31 to the data in order to quantify CBF in
absolute units. CBF map images were given an upper threshold
of 5 to remove large outliers. This was determined based on the
histogram of voxel intensities, in which some scans displayed a
small number of single voxels with large intensities between 5
and 80 having a large influence on the mean. Nonzero mean
and standard deviation CBF were calculated using FSLstats.
Statistical analysis was performed in Graphpad Prism (Ver-
sion 8, La Jolla, CA). Data are shown as mean +/– standard
deviation (SD). Changes over time were analyzed using a re-
peated measures ANOVA, fitting a mixed effects model to ac-
count for missing values, and the criterion for statistical signif-
icance was P < .05. Where statistically significant differences
were found, post-hoc testing to compare individual time points
was performed using the Tukey-Kramer multiple comparisons
test.
Results
BP and Body Weight
Mean body weight increased over time from 123.0 +/– 6.78
g at 2 months old to 201.5 +/– 19.7 g at 6 months (F(2, 14) =
62.55, P< .0001, Fig 1A). Animals showed a consistent increase
in systolic (F(2,452) = 148.4, P < .0001) and diastolic (F(2,452)
= 109.2, P < .0001) BP over the duration of the study (Fig 1B
and C). Systolic BP increased 28% between 2 and 4 months
(P < .0001), and increased 11% between 4 and 6 months (P <
.0001). Diastolic BP increased 22% between 2 and 4 months
(P < .0001), and increased 27% between 4 and 6 months (P <
.0001). Pulse pressure changed significantly over time (F(2, 452)
= 15.0, P < .0001), increasing by 61% between 2 and 4 months
(P < .0001), and decreasing by 49% between 4 and 6 months
(P < .0001, Fig 1D).
BOLD fMRI
Analysis of BOLD fMRI data was performed in FEAT (Fig 2)
and was used to quantify three aspects of the BOLD signal:
number of active voxels in S1FL, maximum % signal change
in S1FL, and mean % signal change in S1FL (Fig 3). The num-
ber of active voxels in S1FL significantly decreased over time
(F(2, 16) = 4.834, P = .0228) with post-hoc testing showing a
significant decrease between 4 and 6 months from 71 +/– 32
voxels to 29 +/– 26 voxels (P = .0254). Maximum and mean
% BOLD signal change showed no significant change over time
(Max F(2, 16) = 2.139, P = .1502. Mean F(2, 16) = 2.827,
P = .0888).
Functional MR Spectroscopy
At the first time point measured (2 months), mean glutamate
change with activation (Glu) was .99645+ 1.69. No significant
change was observed over time (F(2, 11) = 1.317, P = .3071,
Fig 4A). Analysis was also performed on the NAA signal, which
was 1.58 +/– 2 at 2 months and did not change significantly
over time (F(2, 14) = 1.086, P = .3642, Fig 4B).
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Fig 1. Individual rat weights at 2, 4, and 6 months of age (A). Mean rat systolic blood pressure (B), diastolic blood pressure (C), and pulse
pressure (D) at 2, 4, and 6 months of age (Number = 8). *** = P < .0001
Arterial Spin Labeling
Mean CBF significantly changed over time (F(2, 18) = 8.738,
P = .017, Fig 5). Post-hoc testing showed a significant increase
from 1.616 + .253 mL/mg/min at 2 months old to 2.422 + .486
at 4 months old (P = .0285). CBF at 6 months was also signifi-
cantly greater than 2 months (P = .0110).
Discussion
This study used fMRI to observe, for the first time, changes in
the BOLD signal and CBF over time in SHRs, as animals pro-
gressed from normotension to chronic hypertension. This study
also observed glutamate turnover and NAA levels in SHRs for
the first time. Propofol was determined to be a suitable anes-
thetic for the detection of the BOLD signal, and with no detri-
mental effects on animal health, as we have previously found
in healthy aging animals.15 BP increased significantly between
each time point. Systolic BP and diastolic BP increased at dif-
ferent rates, causing pulse pressure to increase between 2 and
4 months and return to baseline between 4 and 6 months.
This change in BP correlated with previous measurements of
SHRs.14 The size of the BOLD signal in S1FL increased be-
tween 2 and 4 months and also returned to baseline between
4 and 6 months. CBF increased between 2 and 4 months, and
remained high at 6 months old. Functional MR spectroscopy
showed no significant change in glutamate turnover. We chose
6 months as a humane end point for this study, as the survival
rate for SHRs at 6 months old is 98%,32 and before any other
health problems, such as kidney failure, may present, which
could produce ill effects in combination with the anesthetic.
In the acute stage of hypertension, ie, ∼4 months in
SHRs,14,32 adaptive changes are thought to occur in the brain’s
vasculature.11,13 As the BOLD response is not significantly al-
tered at the 4month time point, when pulse pressure is the high-
est, these adaptations may be linked to pulse pressure rather
than the increased systolic BP. The decrease in pulse pressure,
as diastolic BP increases more rapidly, may then be the point
in which adaptive changes to the vascular become patholog-
ical. Previous studies suggest that SHRs have been shown to
favor eutrophic remodeling, rather than hypertrophic remodel-
ing. In eutrophic remodeling, muscle in the arteries rearranges
to narrow the lumen, and in hypertrophic remodeling, growth
of new smooth muscle and perivascular cells occurs. These re-
sults suggest that eutrophic remodeling may occur in the acute
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Fig 2. Example images displaying primary somatosensory cortex,
forepaw region activation in a representative rat.
stage, to preserve vascular reactivity, while hypertrophic re-
modeling occurs in the chronic stage and decreases reactiv-
ity, which is thought to be how hypertension progresses in
humans.6,7
It is important to note that the BOLD signal at 2 months
old, when animals are still normotensive, is much lower than
observed in our previous work in healthy 7-month old rats.15
A possible explanation for this is that vascular or signaling
changes observed in SHRs may be genetic, and begin prior to
the onset of hypertension. This is supported by evidence seen
in human studies that suggests a hereditary component to neu-
rovascular adaptive or pathological changes in hypertension.33
However, to investigate this, further study comparing 2-month
old SHRs with age matched Wistar Kyoto rats would be re-
quired. An alternative explanation may be that the rat so-
matosensory cortex is not yet fully developed before 6 months
old, and Wistar Kyoto rats may exhibit the same low base-
line. A study at 4.7T on Sprague-Dawley rats showed that the
size of the active region in the somatosensory cortex only in-
creased until post-natal day 20, after which activation patters
remained the same into young adulthood. Signal intensity did
increase between these time points.34 However, this study only
observed one “adult” time point, while rats’ brains are still
thought to be developing up to 6months old,35 and so observing
age-matched Wistar Kyoto rats would be beneficial to investi-
gate if the BOLD response does change in this strain prior to
6 months.
ASL for CBF quantification showed an increase in CBF
from 4 months onward, with no change at 6 months. This sug-
gests that approximately halfway through the development of
chronic hypertension, cerebral autoregulation cannot compen-
sate for the sustained increase in BP. In healthy animals, tran-
sient systemic BP increases are counteracted by mechanisms
of cerebral autoregulation to prevent hyperperfusion, which
can be damaging to the brain. The elevated CBF observed
here suggests that these mechanisms are less effective at this
time point, either through inhibition of signaling, or through
reduced sensitivity of remodeled vessels. This supports previ-
ous observations in rodents, in which two-photon microscopy
in 40-week old SHRs showed a sustained increase in CBF.36
However, these findings in SHRS contradict previous research
in humans, in which autoregulation is shifted in hypertensive
subjects to counteract the effect of hypertension. When study-
ing cerebral autoregulation between normotensive and hyper-
tensive subjects, CBF has been shown to be the same in both
groups when measured at each group’s mean BP.2 In the longer
term, human studies have shown that CBF is reduced below
baseline, due to thickening of vascular smooth muscle and col-
lagen deposition in arteries and veins, which reduces lumen di-
ameter and distensibility.3,37 Whether this occurs in SHRs may
require studying animals for 12 months or more.36 If CBF re-
mains high throughout the lifetime of SHRs, then an alterna-
tive model of hypertension may be more appropriate for future
studies.5
No significant changes were seen in Glu at any time point.
If synaptic activity or neuronal metabolism were affected by
chronic hypertension, a decrease in glutamate would be ex-
pected. This would represent either a decrease in glutamate
release, or a decrease in metabolic activity behind glutamate
turnover.38 Impairment of neurovascular coupling, reducing
delivery of oxygen and glucose during neuronal activity, would
be expected to reduce neuronal energy production,39 which
would reduce cellular processes, such as glutamate turnover.
That a change in glutamate is not observed would suggest
that the changes shown in BP, CBF, and vascular reactiv-
ity are not impairing neuronal metabolism or synaptic activ-
ity at this point. NAA levels, a marker for neuronal viability,
also do not change, suggesting that neuronal death does not
occur at this stage. While further study using longer fMRS
scans is needed, as SNR using this method was suboptimal,
preservation of glutamate turnover rate and synaptic activity
at 6 months suggests that the neuronal damage and cognitive
deficits develop more slowly than chronic hypertension. If fur-
ther time points were investigated with improved SNR, the time
point at which synaptic impairment and neuronal death begin
might be determined, indicating the possibility of a window in
which neuroprotective strategies may be of benefit in chronic
hypertension.
This study shows a clear change in BOLD response to
forepaw stimulation and resting CBF in SHRs as animals age
and hypertension develops. CBF increases at 4 months and re-
mains elevated at 6 months. The BOLD signal reveals that the
number of active voxels in the S1FL region decreases signif-
icantly between 4 and 6 months, while the magnitude of the
BOLD signal does not significantly change. This suggests that
while cerebral autoregulation is impaired in the acute stage
of hypertension, protective mechanisms are active, which pre-
serve the BOLD response at this stage, and the BOLD response
is only affected in the chronic stage as pathological changes oc-
cur, and that neuronal damage does not occur at this stage.
It is important to note that an upward trend was observed in
BOLD signal intensity over time. While it was not statistically
significant in this study, if a larger cohort and/or longer study
showed a significant increase in signal intensity, this would indi-
cate a more complex effect of BP/CBF on neurovascular cou-
pling. Additionally, glutamate change with activation became
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Fig 3. Bar graphs showing the number of active voxels in somatosensory cortex, forepaw region (S1FL) (A), maximum BOLD signal change
in S1FL (B), and mean BOLD signal change of all active voxels in S1FL (C). Error bars indicate standard deviation. Lines marked * indicate
significant difference with P < .05. number of values = 6, 6, and 7 at 2, 4, and 6 months, respectively.
negative at later time points; however, this change was also not
significant. Reduction of neurotransmitter turnover, combined
with increased local BOLD response, would suggest an uncou-
pling of neuronal and vascular activity with chronic hyperten-
sion.
To our knowledge, this study is the first longitudinal fMRI
study in hypertensive rats. This study does have the limitation
of variable N between time points, due to technical issues with
monitoring equipment in some scans. As this method had not
previously been used in SHRs, we did not perform additional
scans to account for missing data points, in order to minimize
welfare risks from repeated anesthesia in a short time. This lim-
itation can be rectified in a future study. In the current study,
we only used female rats, to prevent any risk of fighting that
may arise in longer term group housed males, and future stud-
ies are relevant to both males and females. A future study may
also require larger animal numbers, and the data here can be
used in prospective power calculations. The methods, which
were initially developed using a rat model of healthy aging,15
were adapted for SHR physiology, as during the anesthetic test-
ing prior to experiments, after cannulating the tail vein, the tail
vein rapidly constricted and blocked the application of propo-
fol. As this was observed before hypertension developed, this
is likely an inherent trait of the SHR strain, similar to other
inherited adaptive traits seen in humans with a family history
of hypertension.33 This was mitigated through application of
lidocaine to the base of the tail, preventing the vein from con-
stricting and allowing for 1 hour of propofol application before
animals were returned to isoflurane. This may prevent longer
scans from being performed, and so other scans may need to
be removed to allow time for longer MRS scans in future ex-
periments. It may also be feasible to use another model of
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Fig 4. Glutamate (Glu) turnover in somatosensory cortex, forepaw
region (A). N-acetyl aspartate (NAA) levels in somatosensory cortex
over time (B). Error bars indicate standard deviation. Lines marked *
indicate significant difference with P < .05 (A). number of values =
6, 8, and 7 at 2, 4, and 6 months, respectively.
hypertension, for example, salt and mineralocorticoid-induced
hypertension in Wistar rats,5 thus removing any hereditary fac-
tors that may be present in SHRs, including, for example, the
impact such factors may have on vein constriction. This would
also allow the age of onset of hypertension to be determined by
the researcher, rather than by the animals’ genetics. However,
the advantage of using SHRs is that the progression of hyper-
tension is well characterized and has low variability between
animals. Inducing hypertension may have increased variability
due to factors, such as human error, or stress on rats from the
cumulative effect of multiple injections.5 The noninvasive, mul-
tiparametric MRI protocol used here shows for the first time
a link between BP, CBF, and BOLD signal in rats as hyper-
tension progresses. Applying these methods to further study of
SHRs and other rodent models of hypertension could be ben-
eficial in identifying how genetic and environmental factors in
hypertensive subjects can affect brain health and function, and
in the development of treatment for hypertension-related cog-
nitive impairments.
Fig 5. Resting CBF at bregma. Error bars indicate standard devi-
ation. Lines marked * indicate significant difference with P < .05.
number of values = 7.
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